Ana
Patiño García
Consultora Investigadora
Radboud University Nijmegen Medical Centre
Nimega, HolandaPublicaciones en colaboración con investigadores/as de Radboud University Nijmegen Medical Centre (4)
2023
-
Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes
The Lancet. Oncology, Vol. 24, Núm. 1, pp. 91-106
2022
-
SLC7A8 coding for LAT2 is associated with early disease progression in osteosarcoma and transports doxorubicin
Frontiers in Pharmacology, Vol. 13
2014
-
Influence of genetic variants in TPMT and COMT associated with cisplatin induced hearing loss in patients with cancer: Two new cohorts and a meta-analysis reveal significant heterogeneity between cohorts
PLoS ONE, Vol. 9, Núm. 12
-
The role of the MTHFR 677C>T polymorphism in methotrexate-induced liver toxicity: A meta-analysis in patients with cancer
Pharmacogenomics Journal, Vol. 14, Núm. 2, pp. 115-119